Feedback
OncLive®
AJMC®
Pharmacy Times®
Specialty Pharmacy Times

Features

David F. Kisor, BSPharm, PharmD, RPh, and Jon E. Sprague, RPh, PhD
The application of genetic data to effectively influence health care outcomes is poised for rapid acceptance. Genetic testing can provide results that can be used to make the best therapeutic choices.
Katherine Backes, PharmD, BCACP, Sara Griesbach, PharmD, BCPS, BCACP, AE-C, Sue Wilhelm, RPh, BCPS, and Gary Plank, PharmD
There is a need for continued adverse event management for patients receiving oral chemotherapy due to the high incidence of adverse events and discontinuation rates. Pharmacists play a unique role in helping patients manage complicated dosing regimens, drug interactions, and adverse event profiles of oral chemotherapy.
Richard T. Miller, RPh, MBA, and Mike Ellis, BSPharm
As part of its pharmacist-driven ConnectedCare Oral Oncology Program, Walgreens Specialty Pharmacy recently conducted a unique 3-month monitored-dispense pilot program, which reflects continued innovation, additional cost savings, and improved health care system communication.
Quintin Jessee, RPh, DPh
Core standards are important for any specialty pharmacy business. This overview not only provides helpful information for companies undergoing URAC accreditation, but also offers a refresher for currently accredited organizations.
Keith L. Cook, RPh, and Leslie A. Yendro, RN
This case study from Avella Wholesale demonstrates the necessary strategies and steps for successful catering to a niche market.
Thomas Morrow, MD
Discover a revolutionary, efficient, and effective way to amplify the "high touch" of specialty pharmacy with the use of technology as patients embrace new tools to monitor their health.
Molly Burich
US manufacturers prepare for expanding biosimilar market opportunities as this exciting landscape takes shape. The production of biosimilars poses challenges as pharma looks to curb health care spending.
Logan E. Davis, PharmD, and Chris Newlin, PharmD
Home infusion pharmacy services have the potential to expand a specialty pharmacy operation with a focus on coordination of care. Here's how this niche business has changed, along with a road map for establishing a home infusion therapy service line.
Stacey Ness, PharmD, MSCS, AAHIVP
The approval of tofacitinib (Xeljanz) brings a new therapy to the market that could have a big impact on the rheumatoid arthritis treatment paradigm.
David Hileman, RPh
Today’s hub programs are “patient solution centers,” connecting patients with all the health care professionals who are involved in their care. The utilization of hubs is integral to the future of specialty products.
Pharmacy Times
Intellisphere, LLC
666 Plainsboro Road
Building 300
Plainsboro, NJ 08536
P: 609-716-7777
F: 609-716-4747

Copyright Pharmacy Times 2006-2012
Intellisphere, LLC. All Rights Reserved.